MYL-1401H

MYL-1401H · Mylan Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MYL-1401H, covering 2022-02-14 to 2022-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study With MYL-1401H and Neulasta [Phase 3]